A detailed history of State Of Wisconsin Investment Board transactions in Protagonist Therapeutics, Inc stock. As of the latest transaction made, State Of Wisconsin Investment Board holds 47,160 shares of PTGX stock, worth $1.92 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
47,160
Previous 55,951 15.71%
Holding current value
$1.92 Million
Previous $1.94 Million 9.34%
% of portfolio
0.01%
Previous 0.01%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$33.72 - $47.33 $296,432 - $416,078
-8,791 Reduced 15.71%
47,160 $2.12 Million
Q2 2024

Aug 14, 2024

BUY
$24.66 - $34.8 $356,706 - $503,381
14,465 Added 34.87%
55,951 $1.94 Million
Q1 2024

May 14, 2024

BUY
$21.79 - $32.15 $36,759 - $54,237
1,687 Added 4.24%
41,486 $1.2 Million
Q4 2023

Feb 12, 2024

SELL
$14.05 - $23.44 $304,632 - $508,226
-21,682 Reduced 35.27%
39,799 $912,000
Q3 2023

Nov 14, 2023

BUY
$16.68 - $23.66 $196,890 - $279,282
11,804 Added 23.76%
61,481 $1.03 Million
Q2 2023

Aug 14, 2023

BUY
$18.02 - $29.36 $243,414 - $396,594
13,508 Added 37.35%
49,677 $1.37 Million
Q1 2023

May 15, 2023

SELL
$10.78 - $25.38 $819,560 - $1.93 Million
-76,026 Reduced 67.76%
36,169 $831,000
Q4 2022

Feb 14, 2023

BUY
$7.36 - $11.17 $512,859 - $778,347
69,682 Added 163.91%
112,195 $1.22 Million
Q3 2022

Nov 14, 2022

SELL
$7.86 - $11.71 $14,305 - $21,312
-1,820 Reduced 4.11%
42,513 $358,000
Q2 2022

Aug 15, 2022

SELL
$7.06 - $25.52 $64,719 - $233,941
-9,167 Reduced 17.13%
44,333 $351,000
Q1 2022

May 13, 2022

SELL
$23.34 - $36.08 $259,074 - $400,488
-11,100 Reduced 17.18%
53,500 $1.27 Million
Q4 2021

Feb 11, 2022

SELL
$17.63 - $37.1 $116,358 - $244,860
-6,600 Reduced 9.27%
64,600 $2.21 Million
Q3 2021

Nov 12, 2021

BUY
$12.95 - $49.69 $124,320 - $477,024
9,600 Added 15.58%
71,200 $1.26 Million
Q2 2021

Aug 12, 2021

BUY
$25.57 - $44.88 $202,003 - $354,552
7,900 Added 14.71%
61,600 $2.77 Million
Q1 2021

May 17, 2021

SELL
$19.02 - $31.15 $32,334 - $52,955
-1,700 Reduced 3.07%
53,700 $1.39 Million
Q4 2020

Feb 03, 2021

BUY
$18.49 - $25.13 $46,224 - $62,825
2,500 Added 4.73%
55,400 $1.12 Million
Q3 2020

Nov 16, 2020

BUY
$15.19 - $22.4 $803,551 - $1.18 Million
52,900 New
52,900 $1.03 Million
Q1 2020

May 06, 2020

SELL
$5.4 - $9.22 $123,120 - $210,216
-22,800 Closed
0 $0
Q3 2019

Nov 12, 2019

BUY
$9.41 - $16.56 $214,548 - $377,567
22,800 New
22,800 $274,000

Others Institutions Holding PTGX

About Protagonist Therapeutics, Inc


  • Ticker PTGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,084,100
  • Market Cap $2B
  • Description
  • Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...
More about PTGX
Track This Portfolio

Track State Of Wisconsin Investment Board Portfolio

Follow State Of Wisconsin Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wisconsin Investment Board with notifications on news.